Wikipedia -WSS

Wikipedia

author：explore 2025-09-29 12:30:29 - browse：7

Daphne Koller -- biotech coverage from STAT — Daphne Koller, early biotech AI entrant Insitro's founder, CEO and board member. Courtesy Jerrick Mitra/Insitro

New artificial intelligence technologies made headlines last year for their ability to do everything from generating fake musical duets to understanding how proteins fold. But in biotech, one of the most well-funded AI players has been quiet.

Insitro, a South San Francisco firm, was founded in 2018 by Daphne Koller, who had previously been a Stanford professor, a 2004 MacArthur “genius” grant recipient, and the co-founder and co-CEO of the online course company Coursera. It raised more than $643 million in venture capital, according to PitchBook, from investors including T. Rowe Price, ARCH Venture Partners, and Casdin Capital. The company now has more than 260 employees spread out over 107,000 square feet of laboratory and office space.

But what exactly is Koller building?

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Alkermes shareholders re
Next article： Providers still hesitate to prescribe buprenorphine, study finds

explore

WSS

Elizabeth Warren probes abortion access

Review: 'Barbie' will hit you like a shot in the heart

Russian special forces kill a gunman who broke into a private house near Moscow

Will.i.am, Britney Spears release new single, 'Mind Your Business'

Body of missing toddler recovered in Delaware River days after flood: Police

Fentanyl is making it harder to start addiction treatment

leisure time

Wikipedia

focus

Guidelines to prevent youth baseball injuries need more muscle

Southern California school board OKs curriculum after Gov. Gavin Newsom threatened a $1.5M fine

Peter Hotez and the public health issue of online harassment

Death toll from an explosion and collapse of a Paris building in June climbs to 3

Heart attack and stroke risk calculators need revising

7 of the most gruesome medical devices in history

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Citing H5N1 threat, CDC urges peak flu monitoring this summer

Cancer drug shortages should be causing more outrage

Review: 'Barbie' will hit you like a shot in the heart

entertainment

ASCO eve: Let’s set the table for this year's meeting

In new study, freeze

Cytokinetics sells Royalty Pharma a share of its heart drug for up to $575M

New rules on organ donation and transplantation 'will bring chaos'

Biogen joins immunology wave with $1.15 billion acquisition of HI

FDA poised to publish guidelines for clinical trial diversity

knowledge

explore

hotspot

leisure time